Leesa Gentry's most recent trade in RenovoRx Inc was a trade of 6,619 Stock Option done . Disclosure was reported to the exchange on July 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| RenovoRx Inc | Leesa Gentry | Chief Clinical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 6,619 | 6,619 | - | - | Stock Option | |
| RenovoRx Inc | Leesa Gentry | Chief Clinical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2025 | 26,477 | 26,477 | - | - | Stock Option | |
| RenovoRx Inc | Leesa Gentry | Chief Clinical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 190,000 | 190,000 | - | - | Options |